Differential regulation of IL-2 and IL-4 in patients with tobacco-related oral squamous cell carcinoma

Oral Diseases

Volumn 12, Issue 5, 2006, Pages 455-462

  Manchanda, P ^a,b   Sharma, S C ^a   Das, S N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b BOSTON COLLEGE   (United States)

Author keywords

Interleukin 2; Interleukin 4; Oral cancer; T cell subsets

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CANCER STAGING; CD4 CD8 RATIO; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE CULTURE; MALE; MOUTH CARCINOMA; NATURAL KILLER CELL; PATIENT SELECTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TOBACCO;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, DIFFERENTIATION; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; T-LYMPHOCYTE SUBSETS; TOBACCO, SMOKELESS;

EID: 33747444946     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01220.x     Document Type: Article

References (41)

1. Agarwal A, Rani M, Saha GK et al (2003). Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Cancer Invest 32: 15-28.
2. Chang DM, Su WL, Chu SJ (2002). The expression and significance of intra-cellular T-helper cytokines in systemic lupus erythematosus. Immunol Invest 31: 1-12.
3. + T-cell subsets in vivo. Immuno Rev 123: 189-197.
4. Das SN, Khanna NN, Khanna S (1983). Delayed hypersensitivity in patients with squamous cell carcinoma of the oral cavity. Ann Acad Med Singapore 12: 412-416.
5. Das SN, Khanna NN, Khanna S (1986). In vivo and in vitro observation of cellular Immune parameters in squamous cell cancinoma of the oral cavity and its correlation with tumour load and prognosis. Cancer Invest 4: 207-216.
6. Del Prete GF, DelCarli M, Ricci M, Romagnani S (1991). Helper activity for immunoglobulin synthesis of T-helper type 1 (Th1) and Th2 human T-cell clones; the help of Th1 clones is limited by their cytotoxic capacity. J Exp Med 174: 809-813.
7. Gajewski TF, Fitch FW (1988). Antiproliferative effects of IFN-γ in immune regulation I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T-lymphocyte clones. J Immunol 140: 4245-4252.
8. Ghosh P, Komschlies KL, Cippitelli M et al (1995). Gradual loss of T-helper 1 populations in spleen of mice during progressive tumour growth. J Natl Cancer Inst 87: 1478-1483.
9. Goto S, Sato M, Kaneko R et al (1999). Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother 48: 435-442.
10. Jung T, Lack G, Schauer U et al (1995). Allergens, IgE1 mediators inflammatory mechanisms. Decreased frequency of interferon-γ and interleukin-2 producing cells in patients with atopic diseases measured at the single cell level. J Allergy Clin Immunol 96: 515-527.
11. Kalra R, Singh SP, Savage SM et al (2000). Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 293: 166-171.
12. Kersey JH, Spector BD, Good RA (1973). Primary immunodeficiency disease and cancer: the immunodeficiency cancer registry. Int J Cancer 12: 333-347.
13. Khanna NN, Das SN, Khanna S (1982). Serum immunoglobulins in patients with squamous cell carcinoma of the oral cavity. J Surg Oncol 20: 46-48.
14. Klein G, Boon T (1993). Tumour immunology: present perspectives. Curr Opin Immunol 5: 687-692.
15. Knerer B, Hulla W, Martinek H et al (1996). IL-1 and TNF-α but not IL-2 expression is found in squamous cell carcinomas of the head and neck by RT-PCR. Acta Otolaryngol 116: 132-136.
16. Kuss I, Sato T, Johnson JT, Whiteside TL (1999). Clinical significance of decreased ξ chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res 5: 329-334.
17. Lai P, Rabinowich H, Crowley-Nowick PA et al (1996). Alteration in expression and function of signal transduction proteins in tumour associated NK and T lymphocytes from patients with ovarian CA. Clin Cancer Res 2: 161-173.
18. Le Cam L, Lagier B, Bousquet J, Pene J (1996). Nicotine does not modulate IL-4 and interferon-gamma release from peripheral blood mononuclear cells and T cell clones activated by phorbol myristate acetate and calcium ionophore. Int Arch Allergy Immunol 111: 372-375.
19. Li X, Liu J, Park JK et al (1994). T-cells from renal cell carcinoma patients exhibit an abnormal pattern of κB-specific DNA binding activity: a preliminary report. Cancer Res 54: 5424-5429.
20. Lotze MT (1992). T-cell growth factors and the treatment of patients with cancer. Clin Immunol Immunopathol 62: 47-54.
21. Maggi E, Parronchi P, Manetti R et al (1992). Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148: 2142-2147.
22. Maino VC, Picker LJ (1998). Identification of functional subsets by flowcytometry: Intracellular detection of cytokine expression. Cytometry 34: 207-215.
23. Meyaard L, Hovenkamp E, Keet IPM et al (1996). Single cell analysis of IL-4 and IFN-γ production by T-cells from HIV-infected individuals. J Immunol 157: 2712-2718.
24. Olkowski ZL, Wilkins SA (1975). T-lymphocyte levels in the peripheral blood of patients with cancer of the head and neck. Am. J. Surg 130: 440-444.
25. Palmer RM, Wilson RF, Hasan AS, Scott DA (2005). Mechanism of action of environmental factors-tobacco smoking. J Clin Peridontol 32: 210-213.
26. + T-cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol Immunother 42: 1-8.
27. Petro TM, Schwartzbach SD, Zhang S (1999). Smokeless tobacco and nicotine bring about excessive cytokine responses of murine memory T-cells. Int J immunopharmacol 21: 103-114.
28. Powrie F, Coffman R (1993). Interleukin-4 and interleukin-10 synergize to inhibit cell mediated immunity in vivo. Eur J Immunol 23: 2223-2229.
29. Rabinowich H, Suminami Y, Reichert TE et al (1996). Expression of cytokine genes or proteins and signalling molecules in lymphocytes associated with human ovarian carcinoma. Int J Cancer 68: 276-284.
30. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL (2002). Signaling abnormalities, apoptosis and reduced proliferation of circulating and tumour-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8: 3137-3145.
31. + T-cells secreting Th1 or Th2 cytokines. Immunity 2: 271-297.
32. Saxena RK, Choudhry V, Nath I et al (2004). Normal ranges of some select lymphocyte subpopulations in peripheral blood of normal healthy individuals. Curr. Sci 66: 969-975.
33. Schantz SP, Guillamondegui OM (1988). Developing perspective in head and neck tumour immunology. Prob Gen Surg 5: 99-111.
34. Scully C (1982). The immunology of the cancer of the head and neck with particular reference to oral cancer. Oral Surg 52: 157-169.
35. + T-cells. Ann Rev Immunol 12: 635-673.
36. Stephens M, Lim K, Stephens P, Thomas DW, Lim SH (1998). Molecular characterization of tumour infiltrating lymphocytes in oral squamous cell carcinoma. Cancer Immunol. Immunother 46: 34-40.
37. Wanebo HJ, Jun MY, Strong EW, Oettgen HD (1975). T-cell deficiency in patients with squamous cell carcer of the head and neck. Am J Surg 130: 445-451.
38. Wang MB, Lichenstein A, Mickel RA (1991). Hierarchical immunosuppression of regional lymphnodes in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 105: 517-527.
39. Wang Q, Rodovan C, Tubbs R et al (1995). Selective cytokine gene expression in renal cell carcinoma tumour cells and tumour infiltrating lymphocytes. Int J Cancer 61: 780-785.
40. Whiteside TL (1999). Signalling defects in T-lymphocytes of patients with malignancies. Cancer Immunol Immunother 48: 346-352.
41. Woods KV, El-Naggar A, Clayman GL, Grimm EA (1998). Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58: 3132-3141.